JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB133460

Anti-Src (phospho Y419) antibody [EPR6239(2)]

5

(2 Reviews)

|

(8 Publications)

Rabbit Recombinant Monoclonal SRC phospho Y419 antibody. Suitable for WB and reacts with Rat, Human samples. Cited in 8 publications.

View Alternative Names

SRC1, SRC, Proto-oncogene tyrosine-protein kinase Src, Proto-oncogene c-Src, pp60c-src, p60-Src

6 Images
Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)
  • WB

Unknown

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)

All lanes:

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (ab133460) at 1/1000 dilution

Lane 1:

A431 cell lysate, untreated at 10 µg

Lane 2:

A431 cell lysate, treated with Pervanadate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit IgG at 1/2000 dilution

Predicted band size: 60 kDa

false

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)
  • WB

Lab

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)

Purified format.

Blocking Buffer : 5% NFDM/TBST

Diluting buffer : 5% NFDM /TBST

All lanes:

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (ab133460) at 1/1000 dilution

Lane 1:

A431 (human epidermoid carcinoma) treated with pervanadate whole cell lysate at 20 µg

Lane 2:

Untreated A431 (human epidermoid carcinoma) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 60 kDa

false

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)
  • WB

Lab

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)

Purified format.

Blocking buffer : 5% NFDM/TBST

Diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (ab133460) at 1/1000 dilution

Lane 1:

HeLa (human cervix adenocarcinoma) treated with pervanadate whole cell lysate at 20 µg

Lane 2:

Untreated HeLa (human cervix adenocarcinoma) treated with pervanadate whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 60 kDa

false

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)
  • WB

Lab

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)

Purified format.

Blocking buffer : 5% NFDM/TBST

Diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (ab133460) at 1/1000 dilution

Lane 1:

Untreated C6 (rat glioma) whole cell lysate at 10 µg

Lane 2:

C6 (rat glioma) treated with pervanadate whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 60 kDa

false

OI-RD Scanning - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)
  • WB

CiteAb

Western blot - Anti-Src (phospho Y419) antibody [EPR6239(2)] (AB133460)

Src (phospho Y419) western blot using anti-Src (phospho Y419) antibody [EPR6239(2)] ab133460. Publication image and figure legend from Li, X., Wang, F., et al., 2019, BMC Ophthalmol, PubMed 31703690.

ab133460 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab133460 please see the product overview.

The c-Src kinase was activated by inflammatory factors and high glucose a Left, the expressions of c-Src and p-Src418 (active c-Src kinase) were examined by western blot at 30 mins after treatment with inflammatory factors in HLE-B3 cells. Right, the relative expression of p-Src418, radio of p-Src418/c-Src. b Left, the expressions of c-Src and p-Src418 were examined by western blot in different concentrations of glucose. Right, the relative expression of p-Src418, radio of p-Src418/c-Src. (**p < 0.01 compared with control, n = 3)

false

  • Carrier free

    Anti-Src (phospho Y419) antibody [EPR6239(2)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR6239(2)

Isotype

IgG

Carrier free

No

Reacts with

Rat, Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

ab133460 is an antibody to Tyr419 (with Met). This is the equivalent as Tyr418 (without Met).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Product details

Species reactivity
Mouse: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Src also known as c-Src is a protein-tyrosine kinase involved in the regulation of many cellular processes. The molecular weight of Src is approximately 60 kDa. Src is ubiquitously expressed in human tissues but shows increased expression in specific tissues like the brain and epithelial cells. This protein has several important roles in cellular signal transduction particularly influencing cell growth differentiation and survival.
Biological function summary

The Src protein interacts with other proteins to modulate cell adhesion motility and angiogenesis forming part of larger protein complexes. Src phosphorylates specific tyrosine residues on its substrates altering their activity interaction or stability. This activity positions Src as an important factor in managing cell communication and structural organization. Src's interaction with focal adhesion complexes emphasizes its functionality in cellular structural integrity and intracellular communication pathways.

Pathways

Src plays a critical role in the integrin and growth factor receptor signaling pathways mediating cross-talk between cell surface receptors and intricate signaling cascades. It closely associates with focal adhesion kinase (FAK) within these pathways influencing cytoskeletal rearrangements and cell movement. Src's function in the epidermal growth factor receptor (EGFR) signaling pathway likewise demonstrates its importance in regulating cellular proliferation and survival mechanisms.

Src has significant implications in oncogenesis particularly in colorectal and breast cancers. Overexpression or abnormal activity of Src associates with tumor progression and metastasis. Within these cancers Src cooperates with various proteins like the EGFR amplifying aberrant cell signaling that contributes to uncontrolled cell growth. Investigating Src's role and regulation could offer insights into novel therapeutic strategies for controlling Src activity in cancer treatment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors (PubMed : 34234773). Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN) (Probable). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN) (PubMed : 21411625). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1 (Probable). Phosphorylates PKP3 at 'Tyr-195' in response to reactive oxygen species, which may cause the release of PKP3 from desmosome cell junctions into the cytoplasm (PubMed : 25501895). Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors (By similarity). Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1 (PubMed : 11389730). Plays a role in EGF-mediated calcium-activated chloride channel activation (PubMed : 18586953). Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of GRK2, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor (Probable). Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus (PubMed : 7853507). Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function (PubMed : 14585963, PubMed : 8755529). Upon activation of the G(q)-dependent KISS1/KISS1R signaling pathway, active SRC is recruited, together with the phosphatase DUSP18, to the KISS1R C-terminus (PubMed : 38346942). This leads to DUSP18-mediated SRC dephosphorylation and inactivation, down-regulation of osteoclast differentiation and activity, and consequently suppression of bone resorption (By similarity). Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase (PubMed : 12615910). Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation (PubMed : 16186108). Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731' (PubMed : 20100835, PubMed : 21309750). Enhances RIGI-elicited antiviral signaling (PubMed : 19419966). Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376' (PubMed : 14585963). Phosphorylates BCAR1 at 'Tyr-128' (PubMed : 22710723). Phosphorylates CBLC at multiple tyrosine residues, phosphorylation at 'Tyr-341' activates CBLC E3 activity (PubMed : 20525694). Phosphorylates synaptic vesicle protein synaptophysin (SYP) (By similarity). Involved in anchorage-independent cell growth (PubMed : 19307596). Required for podosome formation (By similarity). Mediates IL6 signaling by activating YAP1-NOTCH pathway to induce inflammation-induced epithelial regeneration (PubMed : 25731159). Phosphorylates OTUB1, promoting deubiquitination of RPTOR (PubMed : 35927303). Phosphorylates caspase CASP8 at 'Tyr-380' which negatively regulates CASP8 processing and activation, down-regulating CASP8 proapoptotic function (PubMed : 16619028). Mediates laminin-induced activation of RAC1 signaling through phosphorylation of syntrophin (By similarity).. Isoform 1. Non-receptor protein tyrosine kinase which phosphorylates synaptophysin with high affinity.. Isoform 2. Non-receptor protein tyrosine kinase which shows higher basal kinase activity than isoform 1, possibly due to weakened intramolecular interactions which enhance autophosphorylation of Tyr-419 and subsequent activation (By similarity). The SH3 domain shows reduced affinity with the linker sequence between the SH2 and kinase domains which may account for the increased basal activity (By similarity). Displays altered substrate specificity compared to isoform 1, showing weak affinity for synaptophysin and for peptide substrates containing class I or class II SH3 domain-binding motifs (By similarity). Plays a role in L1CAM-mediated neurite elongation, possibly by acting downstream of L1CAM to drive cytoskeletal rearrangements involved in neurite outgrowth (By similarity).. Isoform 3. Non-receptor protein tyrosine kinase which shows higher basal kinase activity than isoform 1, possibly due to weakened intramolecular interactions which enhance autophosphorylation of Tyr-419 and subsequent activation (By similarity). The SH3 domain shows reduced affinity with the linker sequence between the SH2 and kinase domains which may account for the increased basal activity (By similarity). Displays altered substrate specificity compared to isoform 1, showing weak affinity for synaptophysin and for peptide substrates containing class I or class II SH3 domain-binding motifs (By similarity). Plays a role in neurite elongation (By similarity).
See full target information SRC pY419

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2300115 PubMed37156751

2023

The c-Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance.

Applications

Unspecified application

Species

Unspecified reactive species

Xianteng Wang,Bing Wang,Fang Li,Xingkai Li,Ting Guo,Yushun Gao,Dawei Wang,Weiren Huang

Redox biology 61:102648 PubMed36871182

2023

Meta-data analysis of kidney stone disease highlights ATP1A1 involvement in renal crystal formation.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Li,Xiuli Lu,Zhihao Yu,Haozhen Wang,Bing Gao

Nature cardiovascular research 1:1006-1021 PubMed36910472

2022

Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Derek C Sung,Mei Chen,Martin H Dominguez,Aparna Mahadevan,Xiaowen Chen,Jisheng Yang,Siqi Gao,Aileen A Ren,Alan T Tang,Patricia Mericko,Raiyah Patton,Michelle Lee,Melanie Jannaway,Astrid Nottebaum,Dietmar Vestweber,Joshua P Scallan,Mark L Kahn

The Journal of biological chemistry 295:17281-17297 PubMed33037073

2020

Leptin modulates pancreatic β-cell membrane potential through Src kinase-mediated phosphorylation of NMDA receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Veronica A Cochrane,Yi Wu,Zhongying Yang,Assmaa ElSheikh,Jeremy Dunford,Paul Kievit,Dale A Fortin,Show-Ling Shyng

Toxicology in vitro : an international journal pub 69:104973 PubMed32818624

2020

Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Zhu,Ke Wang,Yu Chen

BMC ophthalmology 19:219 PubMed31703690

2019

The effects of c-Src kinase on EMT signaling pathway in human lens epithelial cells associated with lens diseases.

Applications

Unspecified application

Species

Unspecified reactive species

Xingyu Li,Fang Wang,Meixia Ren,Minjuan Du,Jian Zhou

OncoTargets and therapy 11:7679-7690 PubMed30464516

2018

16-Hydroxycleroda-3,13-dien-15,16-olide induces anoikis in human renal cell carcinoma cells: involvement of focal adhesion disassembly and signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Chi Chen,Bu-Miin Huang,Wei-Chang Lee,Yung-Chia Chen

Journal of medical virology 89:1852-1860 PubMed28480962

2017

Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xia Wang,Zhiqiang Zhang,Huimin Cao,Wenyi Niu,Mingying Li,Xiu'e Xi,Jing Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com